TVGN (Tevogen Bio Holdings) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings ROE % Adjusted to Book Value?

Tevogen Bio Holdings's ROE % for the quarter that ended in Sep. 2024 was 0.00%. Tevogen Bio Holdings's PB Ratio for the quarter that ended in Sep. 2024 was N/A. Tevogen Bio Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.

Tevogen Bio Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Tevogen Bio Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings ROE % Adjusted to Book Value Chart

Tevogen Bio Holdings Annual Data

Trend

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Tevogen Bio Holdings Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial					-	Negative Equity	Negative Equity	-	-

Competitive Comparison of Tevogen Bio Holdings's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Tevogen Bio Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tevogen Bio Holdings's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tevogen Bio Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Tevogen Bio Holdings's ROE % Adjusted to Book Value falls into.

Tevogen Bio Holdings ROE % Adjusted to Book Value Calculation

Tevogen Bio Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-0.04%	/	N/A
	=	N/A

Tevogen Bio Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Tevogen Bio Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (NAS:TVGN) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

G28:Germany

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.